The Methyl-CpG Binding Protein MBD1 is Required for PML-RARalpha Function

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2006 Jan 25

PMID 16432238

Citations 37

Authors

Raffaella Villa

Lluis Morey

Veronica A Raker

Marcus Buschbeck

Arantxa Gutierrez

Francesca De Santis

Massimo Corsaro

Florencio Varas

Daniela Bossi

Saverio Minucci

Pier Giuseppe Pelicci

Luciano Di Croce

Affiliations

Soon will be listed here.

Abstract

PML-RARalpha induces a block of hematopoietic differentiation and acute promyelocytic leukemia. This block is based on its capacity to inactivate target genes by recruiting histone deacetylase (HDAC) and DNA methyltransferase activities. Here we report that MBD1, a member of a conserved family of proteins able to bind methylated DNA, cooperates with PML-RARalpha in transcriptional repression and cellular transformation. PML-RARalpha recruits MBD1 to its target promoter through an HDAC3-mediated mechanism. Binding of HDAC3 and MBD1 is not confined to the promoter region but instead is spread over the locus. Knock-down of HDAC3 expression by RNA interference in acute promyelocytic leukemia cells alleviates PML-RAR-induced promoter silencing. We further demonstrate that retroviral expression of dominant-negative mutants of MBD1 in hematopoietic precursors compromises the ability of PML-RARalpha to block their differentiation and thus restored cell differentiation. Our results demonstrate that PML-RARalpha functions by recruiting an HDAC3-MBD1 complex that contributes to the establishment and maintenance of the silenced chromatin state.

Citing Articles

Light-Activatable MBD-Readers of 5-Methylcytosine Reveal Domain-Dependent Chromatin Association Kinetics In Vivo.

Lin T, Engelhard L, Soldner B, Linser R, Summerer D Adv Sci (Weinh). 2024; 11(11):e2307930.

PMID: 38164822 PMC: 10953577. DOI: 10.1002/advs.202307930.

MBD1/HDAC3-miR-5701-FGFR2 axis promotes the development of gastric cancer.

Zhao C, Miao J, Sun R, Liang R, Chen W, Gao Y Aging (Albany NY). 2022; 14(14):5878-5894.

PMID: 35876658 PMC: 9365560. DOI: 10.18632/aging.204190.

In vivo temporal resolution of acute promyelocytic leukemia progression reveals a role of in suppressing early leukemic transformation.

Mas G, Santoro F, Blanco E, Gamarra Figueroa G, Le Dily F, Frige G Genes Dev. 2022; 36(7-8):451-467.

PMID: 35450883 PMC: 9067408. DOI: 10.1101/gad.349115.121.

The Role of Histone Deacetylase 3 Complex in Nuclear Hormone Receptor Action.

Ishii S Int J Mol Sci. 2021; 22(17).

PMID: 34502048 PMC: 8431225. DOI: 10.3390/ijms22179138.

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?.

turcas C, Moisoiu V, Stefancu A, Jurj A, Iancu S, Teodorescu P Front Oncol. 2020; 10:1024.

PMID: 32695677 PMC: 7336895. DOI: 10.3389/fonc.2020.01024.

References

Ng H, Bird A . Histone deacetylases: silencers for hire. Trends Biochem Sci. 2000; 25(3):121-6. DOI: 10.1016/s0968-0004(00)01551-6. View

Perissi V, Rosenfeld M . Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol. 2005; 6(7):542-54. DOI: 10.1038/nrm1680. View

Wen Y, Perissi V, Staszewski L, Yang W, Krones A, Glass C . The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc Natl Acad Sci U S A. 2000; 97(13):7202-7. PMC: 16523. DOI: 10.1073/pnas.97.13.7202. View

Fujita N, Shimotake N, Ohki I, Chiba T, Saya H, Shirakawa M . Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol Cell Biol. 2000; 20(14):5107-18. PMC: 85960. DOI: 10.1128/MCB.20.14.5107-5118.2000. View

Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S . Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol Cell. 2000; 5(5):811-20. DOI: 10.1016/s1097-2765(00)80321-4. View

Li J, Wang J, Nawaz Z, Liu J, Qin J, Wong J . Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 2000; 19(16):4342-50. PMC: 302030. DOI: 10.1093/emboj/19.16.4342. View

Chen R, Akbarian S, TUDOR M, Jaenisch R . Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet. 2001; 27(3):327-31. DOI: 10.1038/85906. View

Robertson K, Wolffe A . DNA methylation in health and disease. Nat Rev Genet. 2001; 1(1):11-9. DOI: 10.1038/35049533. View

Ohki I, Shimotake N, Fujita N, Jee J, Ikegami T, Nakao M . Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell. 2001; 105(4):487-97. DOI: 10.1016/s0092-8674(01)00324-5. View

10.

Nielsen S, Schneider R, Bauer U, Bannister A, Morrison A, OCarroll D . Rb targets histone H3 methylation and HP1 to promoters. Nature. 2001; 412(6846):561-5. DOI: 10.1038/35087620. View

11.

Guenther M, Barak O, Lazar M . The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol. 2001; 21(18):6091-101. PMC: 87326. DOI: 10.1128/MCB.21.18.6091-6101.2001. View

12.

Frank S, Schroeder M, Fernandez P, Taubert S, Amati B . Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 2001; 15(16):2069-82. PMC: 312758. DOI: 10.1101/gad.906601. View

13.

Bird A . DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16(1):6-21. DOI: 10.1101/gad.947102. View

14.

Fischle W, Dequiedt F, Hendzel M, Guenther M, Lazar M, Voelter W . Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell. 2002; 9(1):45-57. DOI: 10.1016/s1097-2765(01)00429-4. View

15.

Di Croce L, Okret S, Kersten S, Gustafsson J, Parker M, Wahli W . Steroid and nuclear receptors. Villefranche-sur-Mer, France, May 25-27, 1999. EMBO J. 1999; 18(22):6201-10. PMC: 1171683. DOI: 10.1093/emboj/18.22.6201. View

16.

Fuks F, Burgers W, Brehm A, Hughes-Davies L, Kouzarides T . DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet. 1999; 24(1):88-91. DOI: 10.1038/71750. View

17.

Ng H, Jeppesen P, Bird A . Active repression of methylated genes by the chromosomal protein MBD1. Mol Cell Biol. 2000; 20(4):1394-406. PMC: 85293. DOI: 10.1128/MCB.20.4.1394-1406.2000. View

18.

Di Croce L, Raker V, Corsaro M, Fazi F, Fanelli M, Faretta M . Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science. 2002; 295(5557):1079-82. DOI: 10.1126/science.1065173. View

19.

Zhang J, Kalkum M, Chait B, Roeder R . The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell. 2002; 9(3):611-23. DOI: 10.1016/s1097-2765(02)00468-9. View

20.

Li E . Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 2002; 3(9):662-73. DOI: 10.1038/nrg887. View